National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 33137-33138 [2017-15153]
Download as PDF
asabaliauskas on DSKBBXCHB2PROD with NOTICES
Federal Register / Vol. 82, No. 137 / Wednesday, July 19, 2017 / Notices
The meeting agenda will include: (1)
Presentations and discussion on the
processes states use to identify and
follow up on out of range newborn
screening results; (2) a presentation on
phase one of the spinal muscular
atrophy evidence review; (3)
presentations on newborn screening
topics such as the clinical and public
health impact of Critical Congenital
Heart Defects, quality measures in
newborn screening, and a review of
newborn screening technology; and (4)
updates from the Laboratory Standards
and Procedures workgroup, Follow-up
and Treatment workgroup, and
Education and Training workgroup. The
Committee will not be voting on a
proposed addition of a condition to the
RUSP. Agenda items are subject to
change. The final meeting agenda will
be available 2 days prior to the meeting
on the Committee’s Web site: https://
www.hrsa.gov/advisorycommittees/
mchbadvisory/heritabledisorders.
Members of the public will have the
opportunity to provide comments. All
comments are part of the official
Committee record. To submit written
comments or request time for an oral
comment at the meeting, please register
online by 12:00 p.m. on July 28, 2017,
at https://www.achdncmeetings.org/. To
ensure all individuals who have
registered and requested time for oral
comments are accommodated, the
allocated time for comments may be
limited. Individuals associated with
groups or who plan to provide
comments on similar topics may be
asked to combine their comments and
present them through a single
representative. No audiovisual
presentations are permitted. Written
comments should identify the
individual’s name, address, email,
telephone number, professional or
organization affiliation, background or
area of expertise (i.e., parent, family
member, researcher, clinician, public
health) and the topic/subject matter.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify Ann Ferrero using the address
and phone number above at least 10
days prior to the meeting.
Jason E. Bennett,
Director, Division of the Executive Secretariat.
[FR Doc. 2017–15113 Filed 7–18–17; 8:45 am]
BILLING CODE 4165–15–P
VerDate Sep<11>2014
18:49 Jul 18, 2017
Jkt 241001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Findings of Research Misconduct
Office of the Secretary, HHS
Notice.
AGENCY:
ACTION:
Notice is hereby given that
the Office of Research Integrity (ORI)
has taken final action in the following
case:
Alec Mirchandani, Florida Atlantic
University: Based on the report of the
inquiry conducted by Florida Atlantic
University (FAU), the Respondent’s
admission, and analysis conducted by
ORI, ORI found that Mr. Alec
Mirchandani, former post-baccalaureate
research volunteer in the Center for
Complex Systems and Brain Sciences,
Florida Atlantic University (FAU),
engaged in research misconduct in
research supported by National Institute
of Mental Health (NIMH), National
Institutes of Health (NIH), grant 1 R15
MH099590–01A1.
ORI found that Respondent engaged
in research misconduct by knowingly
and intentionally: (1) Fabricating the
results of the T-maze behavioral
experiment for control mice, (2)
falsifying the laboratory and vivarium
entry logs in an effort to cover up his
actions, and (3) reporting the fabricated
and falsified data to his laboratory
supervisors.
Specifically, ORI found that
Respondent knowingly and
intentionally:
• Fabricated the results that he
recorded for the T-maze behavioral
experiment in three of the five TMZ
control mice on the laboratory data
sheets and white board on fourteen (14)
of the sixteen (16) eligible days in June
2016, to make it appear as though he
had conducted the experiments;
• Falsified the animal transfer logs on
twelve (12) of the sixteen (16) eligible
days in June 2016, to make it appear as
though he had conducted the
experiments;
• Fabricated the times he recorded on
the laboratory data sheets on fourteen
(14) of the sixteen (16) eligible days in
June 2016, to make it appear as though
he had conducted the experiments;
• incorporated and recorded the
fabricated and falsified data with his
previous data in his laboratory notebook
and reported the results to his
laboratory supervisor and principal
investigator, such that the experimental
control data (five animals) for
experiments conducted from January
2016–June 30, 2016, were not accurately
represented.
SUMMARY:
PO 00000
Frm 00098
Fmt 4703
Sfmt 4703
33137
Mr. Mirchandani has entered into a
Voluntary Settlement Agreement with
ORI, in which he voluntarily agreed,
beginning on June 29, 2017:
(1) That if within two (2) years from
the effective date of the Agreement,
Respondent receives or applies for U.S.
Public Health Service (PHS) support,
Respondent agrees to have his research
supervised for a period of one (1) year,
beginning on the date of his
employment in a position in which he
receives or applies for PHS support, and
agrees to notify his employer(s)/
institution(s) of the terms of this
supervision. Respondent agrees that
prior to the submission of an
application for PHS support for a
research project on which the
Respondent’s participation is proposed
and prior to Respondent’s participation
in any capacity on PHS-supported
research, Respondent shall ensure that a
plan for supervision of Respondent’s
duties is submitted to ORI for approval.
The supervision plan must be designed
to ensure the scientific integrity of
Respondent’s research contribution.
Respondent agrees that he shall not
participate in any PHS-supported
research until such a supervision plan is
submitted to and approved by ORI.
Respondent agrees to maintain
responsibility for compliance with the
agreed upon supervision plan.
(2) To exclude himself voluntarily
from serving in any advisory capacity to
PHS including, but not limited to,
service on any PHS advisory committee,
board, and/or peer review committee, or
as a consultant for a period of one (1)
year, beginning with the effective date
of the Agreement.
FOR FURTHER INFORMATION CONTACT:
Director, Office of Research Integrity,
1101 Wootton Parkway, Suite 750,
Rockville, MD 20852, (240) 453–8200.
Kathryn M. Partin,
Director, Office of Research Integrity.
[FR Doc. 2017–15159 Filed 7–18–17; 8:45 am]
BILLING CODE 4150–31–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
E:\FR\FM\19JYN1.SGM
19JYN1
33138
Federal Register / Vol. 82, No. 137 / Wednesday, July 19, 2017 / Notices
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01).
Date: August 16, 2017.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Lynn Rust, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room 3G42A, National Institutes of Health/
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20892–9823, (240) 669–5069,
lrust@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: July 14, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–15153 Filed 7–18–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
asabaliauskas on DSKBBXCHB2PROD with NOTICES
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Health and
Retirement.
Date: August 15, 2017.
Time: 1:30 p.m. to 4:00 p.m.
VerDate Sep<11>2014
18:49 Jul 18, 2017
Jkt 241001
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 2W200, 7201 Wisconsin
Ave., Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Kimberly Firth, Ph.D.,
National Institutes of Health, National
Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, Suite 2C212, Bethesda,
MD 20892, 301–402–7702, firthkm@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Jan Li, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5106,
Bethesda, MD 20892, 301.402.9607, Jan.Li@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: July 13, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
Dated: July 13, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–15152 Filed 7–18–17; 8:45 am]
[FR Doc. 2017–15151 Filed 7–18–17; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HOMELAND
SECURITY
National Institutes of Health
Coast Guard
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Special
Emphasis Panel: Cardiovascular and
Respiratory AREA.
Date: August 16, 2017.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Chee Lim, Ph.D., Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive Room 4128,
Bethesda, MD 20892, 301–435–1850, limc4@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel
Shared Instrumentation Biomedical Imaging.
Date: August 18, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00099
Fmt 4703
Sfmt 4703
[Docket No. USCG–2016–0915; OMB
Control Number: 1625–0093]
Collection of Information Under
Review by Office of Management and
Budget
Coast Guard, DHS.
Thirty-day notice requesting
comments.
AGENCY:
ACTION:
In compliance with the
Paperwork Reduction Act of 1995 the
U.S. Coast Guard is forwarding an
Information Collection Request (ICR),
abstracted below, to the Office of
Management and Budget (OMB), Office
of Information and Regulatory Affairs
(OIRA), requesting approval for
reinstatement, without change, of the
following collection of information:
1625–0093, Facilities Transferring Oil or
Hazardous Materials in Bulk—Letter of
Intent and Operations Manual. Our ICR
describes the information we seek to
collect from the public. Review and
comments by OIRA ensure we only
impose paperwork burdens
commensurate with our performance of
duties.
DATES: Comments must reach the Coast
Guard and OIRA on or before August 18,
2017.
ADDRESSES: You may submit comments
identified by Coast Guard docket
number [USCG–2016–0915] to the Coast
Guard using the Federal eRulemaking
Portal at https://www.regulations.gov.
Alternatively, you may submit
comments to OIRA using one of the
following means:
(1) Email: dhsdeskofficer@
omb.eop.gov.
SUMMARY:
E:\FR\FM\19JYN1.SGM
19JYN1
Agencies
[Federal Register Volume 82, Number 137 (Wednesday, July 19, 2017)]
[Notices]
[Pages 33137-33138]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-15153]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections
[[Page 33138]]
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant
applications and the discussions could disclose confidential trade
secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the grant
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01).
Date: August 16, 2017.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892 (Telephone Conference Call).
Contact Person: Lynn Rust, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities, Room
3G42A, National Institutes of Health/NIAID, 5601 Fishers Lane, MSC
9823, Bethesda, MD 20892-9823, (240) 669-5069, lrust@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: July 14, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-15153 Filed 7-18-17; 8:45 am]
BILLING CODE 4140-01-P